Background Patients with rheumatoid arthritis (RA) have a systemic Th1 defect associated with inflammation. Objective To examine the hypothesis that interleukin 17 (IL-17) contributes to this defect. Methods IL-17 effects on Th1 markers were examined on T-bet and interferon γ (IFNγ) expression in peripheral blood mononuclear cells (PBMCs) from patients with RA or healthy controls (HC). Receptor specificities were determined by analysis of the Th1-specific IL-12 receptor β2 (IL-12Rβ2), Th17-specific IL-23R and the common IL-12Rβ1 chain expression. Effects of IL-17 or IFNγ on IL-6, IL-1, IL-8, matrix metalloproteinase-8 (MMP-8) were measured by real-time RT-PCR in RA synovial cells. Results RA PBMCs were less responsive to IL-12-induced IFNγ than HC PBMCs. IL-12 hyporesponsiveness was increased by IL-17 treatment associated with a selective reduction in IL-12Rβ2, but not IL-23R, IL-12Rβ1 or T-bet, which was reversed with IL-17R inhibition. IL-17 inhibited IL-12Rβ2 expression in developing Th1 cells. In RA synovial cells, IL-17 induced IL-6, IL-1, IL-8 and MMP-8, whereas IFNγ haBackground Patients with rheumatoid arthritis (RA) have a systemic Th1 defect associated with inflammation. Objective To examine the hypothesis that interleukin 17 (IL-17) contributes to this defect. Methods IL-17 effects on Th1 markers were examined on T-bet and interferon γ (IFNγ) expression in peripheral blood mononuclear cells (PBMCs) from patients with RA or healthy controls (HC). Receptor specificities were determined by analysis of the Th1-specific IL-12 receptor β2 (IL-12Rβ2), Th17-specific IL-23R and the common IL-12Rβ1 chain expression. Effects of IL-17 or IFNγ on IL-6, IL-1, IL-8, matrix metalloproteinase-8 (MMP-8) were measured by real-time RT-PCR in RA synovial cells. Results RA PBMCs were less responsive to IL-12-induced IFNγ than HC PBMCs. IL-12 hyporesponsiveness was increased by IL-17 treatment associated with a selective reduction in IL-12Rβ2, but not IL-23R, IL-12Rβ1 or T-bet, which was reversed with IL-17R inhibition. IL-17 inhibited IL-12Rβ2 expression in developing Th1 cells. In RA synovial cells, IL-17 induced IL-6, IL-1, IL-8 and MMP-8, whereas IFNγ ha
廈門侖昌碩生物科技有限公司集研發(fā)、生產、銷售、服務及品牌代理為一體的生物技術公司,目前可提供各種抗體、免疫學相關的檢測試劑盒、胎牛血清,動物抗血清等高品質產品及服務,涵蓋分子生物學、細胞生物學、免疫學等生命科學領域。
公司非常注重企業(yè)信息化的建設及企業(yè)平臺的建設,我們內部采用了*的信息處理平臺,保證客戶的需求可以準確、高效處理。
公司成立之初,立足外貿,和部分歐美及亞非國家的客戶建立了良好的合作,隨著國內生物領域的蓬勃發(fā)展,逐步把重心轉移到國內來,為每一位科研人員獻上高品質的產品及服務是我們的使命。
集研發(fā)、生產、銷售、服務及品牌代理為一體的生物技術公司,目前可提供各種抗體、免疫學相關的檢測試劑盒、胎牛血清,動物抗血清等高品質產品及服務,涵蓋分子生物學、細胞生物學、免疫學等生命科學領域。
產地 | 國產 | 級別 | 其他 |
---|
人白介素1β轉換酶(ICE)elisa試劑盒 產品信息